DocMorris (formerly Zur Rose Group AG )

What DocMorris (formerly Zur Rose Group AG ) does

DocMorris AG (formerly Zur Rose Group AG, rebranded 2023) is a Swiss-listed digital health platform (SIX: DOCM) headquartered in Frauenfeld, Switzerland, operating one of Europe's largest online pharmacies. Founded in 1993, the company serves over 12.6 million active customers across Germany, the Netherlands, Spain, France, Portugal, and Switzerland with a workforce of approximately 1,600 employees drawn from 65 nations. Its vision is to provide a single platform connecting patients and customers with doctors, pharmacies, and health insurers.

The company's core product surface is anchored on a digital pharmacy platform for prescription (Rx) and over-the-counter (OTC) medicines, supplemented by a marketplace model with 1,500+ partner pharmacies and sellers that extends product assortment across Europe. Underlying technology includes e-prescription handling, a state-of-the-art 20,000+ square meter logistics hub in Heerlen, Netherlands (purpose-built for the German E-Rezept mandate effective January 1, 2024), the TeleClinic telemedicine subsidiary (acquired 2020) with roughly 1,500 active doctors and over 1.6 million completed telemedical treatments, and an AI Health Companion launched in 2025. The DocMorris Ratgeber serves as a content hub for chronic-care journeys. Sub-brands include PromoFarma (Spain/France), DoctiPharma (France), and brand cooperations with medpex and Apotal in Germany.

DocMorris generates revenue through multiple streams: transaction-based sales of Rx and OTC medicines (CHF 1,186 million in external revenue for 2024/2025, the dominant stream), marketplace commissions on third-party partner sales, high-margin Digital Services including telemedicine and chronic-care programs (growing 63.1% in Q1 2026), and private-label OTC products. The go-to-market combines a digital-first, app-led consumer motion with enterprise partnerships targeting health insurers, pharmaceutical companies, and doctor networks. The company is progressing toward profitability with adjusted EBITDA losses narrowing to CHF -6.3 million in Q1 2026 from CHF -16.1 million a year earlier, targeting EBITDA breakeven by end of 2026 and positive free cash flow in 2027, supported by an AI-First cost-out program.

Name

DocMorris (formerly Zur Rose Group AG )

Legal name

DocMorris AG

Website

https://corporate.docmorris.com

Company type

Public

Founded year

2023

Operating status

Operating

Headcount range

1,001–5,000 employees

Ownership category

akta.pro rank

Product category

Online Pharmacy

NAICS

Pharmacies and Drug Retailers (45611), Pharmacies and Drug Retailers (456110), Offices of Physicians (62111), Offices of Physicians (6211)

SIC

Retail-Drug Stores And Proprietary Stores (5912), Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA)

akta.pro secondary industries

Pharmacy & Health Essentials Delivery (CRAFAFAI), Telepharmacy & Prescription Fulfillment Marketplaces (HLALALAF), Health, Wellness & Pharmacy Marketplaces (CRAFABAF)

Keywords

• Online pharmacy services
• Digital health platform
• Prescription medicines
• Telemedicine services
• Pharmaceutical e-commerce

Headquarters

HQ city

Frauenfeld

HQ country

Switzerland

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Online Pharmacy (Rx & OTC): Core revenue stream from prescription medicines (Rx) and over-the-counter (OTC) products, including health, beauty, and personal care (BPC) products. The Rx business saw 30.4% growth in Q1 2026. The company generated CHF 1,186 million in external revenue in 2024.
2. Marketplace Services: Marketplace model with over 1,500 partner pharmacies and sellers expanding the product catalogue. Revenue derived from marketplace commissions and transaction take rates on products sold by third-party partners.
3. Digital Services: High-margin digital services segment growing 63.1% in Q1 2026, including telemedicine via Teleclinic, professional health services for doctors, health insurers, and pharmaceutical companies, as well as the DocMorris Ratgeber platform.
4. Private Label Products: Own-brand products including nutritional supplements, painkillers, first-aid products, and other OTC medicines complementing the core offering.

Go-to-market motion3 records

Distribution channels8 records

Marketing channels6 records

Core offering

DocMorris operates a digital health ecosystem combining an online pharmacy (Rx and OTC medicines, health, beauty, and personal care products), a marketplace with 1,500+ partner pharmacies and sellers, telemedicine through its TeleClinic subsidiary, and professional health services for insurers and pharmaceutical companies. The platform processes e-prescriptions, supports app-first workflows, and delivers same-day via DocMorris Express, serving over 12 million active customers across Germany, Spain, France, the Netherlands, Portugal, and Switzerland.

Product overview

DocMorris operates as a digital health ecosystem platform consisting of three main business areas: Online Pharmacy (core prescription and OTC medicines), Marketplace Services (with over 1,500 partner pharmacies offering assortment expansion and DocMorris Express same-day delivery), and Professional Health Services (connecting doctors via TeleClinic telemedicine, pharmaceutical companies through the DocMorris Ratgeber digital hub, and health insurers with automated prescribing and billing services). The platform serves over 12 million active customers across Germany, Spain, France, Netherlands, Portugal, and Switzerland, integrating e-prescription handling, telehealth consultations, and AI-powered health support through the AI Health Companion. The portfolio includes main brand DocMorris, sub-brands PromoFarma, DoctiPharma, and TeleClinic, plus brand partnerships with medpex and Apotal.

Differentiator

Problem solved

Functional benefit

Brands

• PromoFarma by DocMorris: Online pharmacy and health marketplace brand serving Spain and France markets.
• DoctiPharma
• TeleClinic
• Apotal
• medpex
• DocMorris Express

Products and services

• DocMorris Online Pharmacy
• PromoFarma by DocMorris
• TeleClinic
• DoctiPharma
• medpex
• Apotal
• DocMorris Express
• DocMorris Ratgeber
• AI Health Companion
• Digital Services for Health Insurers and Pharma Companies

Quantifiable outcome

• Revenue grew 11.1% in full-year 2025; Q1 2026 saw 10.7% year-over-year revenue growth
• +5 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Partnerships

Twelve partnerships are on record, tiered subsidiary, core and minor.

• eHealth-Tec GmbHsubsidiaryTechnology or IntegrationeHealth-Tec GmbH, based in Berlin, is a wholly-owned subsidiary of DocMorris AG providing digital health technology integration services.
• TeleClinic GmbHcoreTechnology or IntegrationTeleClinic GmbH, based in Munich, is a DocMorris subsidiary operating one of Germany's leading telemedicine platforms. Approximately 1,500 doctors actively use the service, which has facilitated over 1.6 million telemedical treatments.
• DocMorris N.V.subsidiaryTechnology or IntegrationDocMorris N.V., based in Heerlen, Netherlands, serves as DocMorris AG's EU representation and operational hub, operating the logistics center and European operations.
• PromoFarma Ecom, S.l.subsidiaryChannel Partner/ Reseller/ DistributorPromoFarma Ecom, S.l., based in Barcelona, operates the Promofarma marketplace brand, DocMorris's online health and beauty marketplace in Spain and France.
• Doctipharma SASsubsidiaryChannel Partner/ Reseller/ DistributorDoctipharma SAS, based in Paris, is DocMorris's subsidiary operating the DoctiPharma online pharmacy brand in France.
• Marketplace Partners (1,500+ pharmacies and sellers)coreChannel Partner/ Reseller/ DistributorOver 1,500 partner pharmacies and sellers across Europe expand DocMorris's product catalogue, enabling assortment expansion and faster delivery options for patients and customers. Partners operate under the DocMorris marketplace model.
• Last-Mile Delivery PartnerscoreStrategic or Co-development PartnerDocMorris partners with last-mile delivery providers to enable same-day delivery via the DocMorris Express service, increasing customer convenience and competitive differentiation.
• medpex (online pharmacy brand cooperation)minorChannel Partner/ Reseller/ DistributorBrand cooperation with medpex, a German online pharmacy, complements DocMorris's service portfolio in Germany, expanding reach and customer access.
• Apotal (online pharmacy brand cooperation)minorChannel Partner/ Reseller/ DistributorBrand cooperation with Apotal, a German online pharmacy, complements DocMorris's service portfolio, further expanding its reach in the German market.
• Pharmaceutical Companies (digital treatment pathway partners)coreStrategic or Co-development PartnerDocMorris partners with pharmaceutical companies to improve digital health journeys for patients, combining e-commerce and telehealth expertise with leading treatment providers' experience for various health conditions. Partnerships are manifested through the DocMorris Ratgeber digital hub.
• Health Insurers (Germany)coreStrategic or Co-development PartnerDocMorris provides health insurers with comprehensive services including medication ordering and management, automated prescribing, direct billing, and qualified pharmaceutical advice, making an active contribution to patient health outcomes.
• Teleclinic Doctors (c. 1,500 physicians)coreChannel Partner/ Reseller/ DistributorApproximately 1,500 doctors actively use the Teleclinic telemedicine service to connect patients with physicians across Germany, completing over 1.6 million telemedical consultations.

Scale indicators13 records

Recent moves5 records

Expansion highlights5 records

Market position

Competitive moat6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/docmorris

Revenue estimate

Valuation estimate

Number of profiles

Profiles20 records

Subsidiaries5 records

Funding overview

Funding rounds4 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DocMorris (formerly Zur Rose Group AG )